comparemela.com

Latest Breaking News On - Crinetics pharmaceuticals inc - Page 11 : comparemela.com

Insiders Are Dumping These 5 Healthcare Stocks

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) is a clinical stage biopharma company that is working on treatments for endocrine-related diseases.

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) COO Jeff E Knight Sells 32,359 Shares

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) COO Jeff E. Knight sold 32,359 shares of Crinetics Pharmaceuticals stock in a transaction dated Friday, March 22nd. The stock was sold at an average price of $44.31, for a total value of $1,433,827.29. Following the completion of the sale, the chief operating officer now owns 52,580 […]

Jonestrading Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $56 00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target raised by Jonestrading from $52.00 to $56.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on CRNX. Citigroup started coverage on Crinetics Pharmaceuticals in a research […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.